{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:52:36Z","timestamp":1725555156215},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10620-017-4900-8","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T04:30:10Z","timestamp":1515126610000},"page":"529-532","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation"],"prefix":"10.1007","volume":"63","author":[{"given":"Gerard","family":"Quigley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Al Ani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"4900_CR1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","volume":"148","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield GM, Mason A, Luketic V, et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology. 2015;148:751\u2013761.","journal-title":"Gastroenterology"},{"key":"4900_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/cgh.2003.50014","volume":"1","author":"CO Zein","year":"2003","unstructured":"Zein CO, Angulo P, Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol. 2003;1:89\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4900_CR3","doi-asserted-by":"crossref","first-page":"e000158","DOI":"10.1136\/bmjgast-2017-000158","volume":"4","author":"S Tan","year":"2017","unstructured":"Tan S, Ayutyanont N, Bhattarai B, et al. Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona. BMJ Open Gastroenterol. 2017;4:e000158.","journal-title":"BMJ Open Gastroenterol"},{"key":"4900_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"4900_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cld.2008.02.008","volume":"12","author":"MG Silveira","year":"2008","unstructured":"Silveira MG, Lindor KD. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clin Liver Dis. 2008;12:425\u2013443.","journal-title":"Clin Liver Dis"},{"key":"4900_CR6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","volume":"60","author":"E Wunsch","year":"2014","unstructured":"Wunsch E, Trottier J, Milkiewicz M, et al. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Hepatology. 2014;60:931\u2013940.","journal-title":"Hepatology"},{"key":"4900_CR7","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease. September 21 2017."},{"key":"4900_CR8","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0168-8278(11)60030-5","volume":"54","author":"KV Kowdley","year":"2011","unstructured":"Kowdley KV, Jones D, Luketic V, et al. An international study evaluating the farnesoid X receptor agonist obeticholic acid as monotherapy in PBC. J Hepatol. 2011;54:S13.","journal-title":"J Hepatol"},{"issue":"9972","key":"4900_CR9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, nonalcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385:956\u2013965.","journal-title":"Lancet"},{"issue":"7","key":"4900_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u2013643.","journal-title":"N Engl J Med"},{"issue":"20","key":"4900_CR11","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1056\/NEJMc1611913","volume":"375","author":"LA Spacek","year":"2016","unstructured":"Spacek LA, Solga SF. Obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:e41.","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4900-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T11:32:17Z","timestamp":1517571137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4900"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4900-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}